Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new version entry (210) was added, updating the Study Status and Arms and Interventions sections and applying revision v3.5.4; this follows the prior revision v3.5.3.
    Difference
    0.2%
    Check dated 2026-05-16T10:12:12.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T05:32:45.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry to the version history and updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:51:06.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    New history entries 204–207 (dated 2026-04-04 to 2026-04-09) appear; the log now includes a Study Status entry in the changes.
    Difference
    0.3%
    Check dated 2026-04-10T21:56:06.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Study Status entries were added and updated across multiple record versions, reflecting changes in the trial's recruitment and operational status.
    Difference
    0.5%
    Check dated 2026-04-03T18:50:05.000Z thumbnail image
  9. Check
    69 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-03-27T12:43:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.